Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
51,368,292
-
Total 13F shares
-
22,010,623
-
Share change
-
+2,992,905
-
Total reported value
-
$384,380,000
-
Price per share
-
$17.46
-
Number of holders
-
71
-
Value change
-
+$52,268,028
-
Number of buys
-
47
-
Number of sells
-
16
Institutional Holders of Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) as of Q4 2020
As of 31 Dec 2020,
Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) was held by
71 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,010,623 shares.
The largest 10 holders included
NEA Management Company, LLC, FRAZIER MANAGEMENT LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Novo Holdings A/S, Rock Springs Capital Management LP, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, BlackRock Inc., DRIEHAUS CAPITAL MANAGEMENT LLC, and Sio Capital Management, LLC.
This page lists
71
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.